A
AREV Life Sciences Global Corp
CNSX:AREV
AREV Life Sciences Global Corp
CNSX:AREV
Price:
0.09
CAD
Market Cap:
CA$2.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
AREV Life Sciences Global Corp
CNSX:AREV
|
CA |
|
C
|
Cementos Argos SA
OTC:CMTSY
|
CO |
|
EIH Associated Hotels Ltd
NSE:EIHAHOTELS
|
IN |
|
R
|
Region Re Ltd
ASX:RGN
|
AU |
|
Asuransi Harta Aman Pratama Tbk PT
IDX:AHAP
|
ID |
Income Statement
Earnings Waterfall
AREV Life Sciences Global Corp
AREV Life Sciences Global Corp
Income Statement
AREV Life Sciences Global Corp
AREV Life Sciences Global Corp
Currency: CAD
| Dec-2018 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
+144%
|
0
+58%
|
0
+17%
|
0
-9%
|
0
-42%
|
0
+5%
|
0
-5%
|
0
-12%
|
0
+53%
|
0
-14%
|
0
-15%
|
0
-2%
|
0
-82%
|
0
-31%
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(2)
|
0
|
(7)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
|
| Selling, General & Administrative |
(2)
|
0
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
|
| Research & Development |
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(2)
N/A
|
0
N/A
|
(7)
N/A
|
(3)
+57%
|
(2)
+50%
|
(2)
-17%
|
(2)
+4%
|
(1)
+62%
|
(1)
-71%
|
(2)
-37%
|
(2)
-4%
|
(2)
-5%
|
(1)
+46%
|
(2)
-89%
|
(2)
-1%
|
(1)
+33%
|
(1)
+56%
|
(0)
+38%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(8)
N/A
|
0
N/A
|
(7)
N/A
|
(3)
+56%
|
(2)
+49%
|
(2)
-17%
|
(2)
+5%
|
(1)
+42%
|
(2)
-44%
|
(2)
-28%
|
(2)
-3%
|
(1)
+50%
|
(1)
+7%
|
(1)
-8%
|
(1)
-2%
|
(1)
-16%
|
(1)
+55%
|
(0)
+40%
|
|
| Net Income | |||||||||||||||||||
| Income from Continuing Operations |
(8)
|
0
|
(7)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(8)
N/A
|
0
N/A
|
(7)
N/A
|
(3)
+56%
|
(2)
+49%
|
(2)
-17%
|
(2)
+5%
|
(1)
+42%
|
(2)
-44%
|
(2)
-28%
|
(2)
-3%
|
(1)
+50%
|
(1)
+7%
|
(1)
-8%
|
(1)
-2%
|
(1)
-16%
|
(1)
+55%
|
(0)
+40%
|
|
| EPS (Diluted) |
-1.31
N/A
|
0
N/A
|
-0.79
N/A
|
-0.36
+54%
|
-0.18
+50%
|
-0.11
+39%
|
-0.1
+9%
|
-0.07
+30%
|
-0.08
-14%
|
-0.09
-12%
|
-0.09
N/A
|
-0.05
+44%
|
-0.03
+40%
|
-0.03
N/A
|
-0.03
N/A
|
-0.04
-33%
|
-0.02
+50%
|
-0.01
+50%
|
|
Switch to:
Switch to:
See Also
Discover More
